TRP_1170x120_12-19-19

U.S. generic drug market

Health systems to form generic drug company

Health systems to form generic drug company

Fed up with high costs and supply shortfalls, several health care systems are banding together to form a nonprofit generic drug company. The health systems — Intermountain Healthcare, Ascension, SSM Health and Trinity Health, in consultation with the U.S. Department of Veterans Affairs — said the new company will make key generic medications more available and

Hikma to buy Roxane for $2.65 billion

Hikma to buy Roxane for $2.65 billion

LONDON — Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S. generic drug market, establishing the company as the sixth-largest generics maker by revenue. The addition of Roxane